Valuation Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 09:50:00 06/03/2026 pm IST			5-day change	1st Jan Change
247.90 ^DKK	-0.30%		+4.20%	-23.78%

07:56pm	Top pharma companies racing to launch a weight-loss pill	RE
07:22pm	NOVO NORDISK : Barclays reaffirms its Neutral rating	ZD

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	16,74,992	21,18,803	31,12,331	27,72,285	14,45,242	11,04,892	-	-
Change	-	26.5%	46.89%	-10.93%	-47.87%	-23.55%	-	-
Enterprise Value (EV) ¹	16,84,152	21,21,013	31,09,107	28,48,764	15,49,238	12,13,659	12,07,198	11,86,051
Change	-	25.94%	46.59%	-8.37%	-45.62%	-21.66%	-0.53%	-1.75%
P/E ratio	35.4x	38.4x	37.5x	27.6x	14.1x	11.7x	11.6x	10.5x
PBR	24x	25.6x	29.4x	19.3x	-	5.03x	4.43x	4x
PEG	-	2.2x	0.7x	1.3x	7.98x	-1.44x	6.98x	1x
Capitalization / Revenue	11.9x	12x	13.4x	9.55x	4.68x	3.88x	3.69x	3.49x
EV / Revenue	12x	12x	13.4x	9.81x	5.01x	4.26x	4.03x	3.75x
EV / EBITDA	26x	25.8x	27.8x	19.3x	10.4x	8.81x	8.49x	7.88x
EV / EBIT	28.7x	28.4x	30.3x	22.2x	12.1x	10.3x	9.95x	9.25x
EV / FCF	57.4x	37x	45.5x	38.6x	26.3x	28.9x	17x	14.1x
FCF Yield	1.74%	2.7%	2.2%	2.59%	3.81%	3.45%	5.87%	7.08%
Dividend per Share ²	5.2	6.2	9.4	11.4	11.7	10.78	11.27	12.54
Rate of return	1.41%	1.32%	1.35%	1.83%	3.6%	4.34%	4.53%	5.04%
EPS ²	10.37	12.22	18.62	22.63	23.03	21.17	21.52	23.67
Distribution rate	50.1%	50.7%	50.5%	50.4%	50.8%	50.9%	52.4%	53%
Net sales ¹	1,40,800	1,76,954	2,32,261	2,90,403	3,09,064	2,84,997	2,99,664	3,16,158
EBITDA ¹	64,669	82,171	1,11,987	1,47,446	1,49,640	1,37,779	1,42,257	1,50,540
EBIT ¹	58,644	74,809	1,02,574	1,28,339	1,27,658	1,17,799	1,21,309	1,28,287
Net income ¹	47,757	55,525	83,683	1,00,988	1,02,434	94,006	94,576	1,00,445
Net Debt ¹	9,160	2,210	-3,224	76,479	1,03,996	1,08,766	1,02,306	81,159
Reference price ²	367.50	469.00	698.10	624.20	325.25	248.65	248.65	248.65
Nbr of stocks (in thousands)	45,57,801	45,17,704	44,58,288	44,41,340	44,43,479	44,43,565	-	-
Announcement Date	02/02/22	01/02/23	31/01/24	05/02/25	03/02/26	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
NOVO NORDISK A/S	11.75x	4.26x	8.81x	4.34%	17TCr
ELI LILLY AND COMPANY	28.9x	10.89x	21.87x	0.67%	88TCr
JOHNSON & JOHNSON	24.39x	5.92x	16.12x	2.21%	58TCr
ABBVIE INC.	25.23x	6.89x	13.83x	2.98%	41TCr
ROCHE HOLDING AG	18.73x	4.61x	11.4x	2.86%	36TCr
ASTRAZENECA PLC	24.72x	5.15x	14.27x	1.69%	30TCr
NOVARTIS AG	21.6x	5.83x	14.37x	2.77%	30TCr
MERCK & CO., INC.	27.13x	4.76x	14.87x	2.91%	29TCr
AMGEN INC.	24.73x	6.28x	11.17x	2.73%	20TCr
GILEAD SCIENCES, INC.	20.12x	6.12x	11.07x	2.24%	18TCr
Average	22.73x	6.07x	13.78x	2.54%	36.7TCr
Weighted average by Cap.	24.24x	6.88x	15.53x	2.18%